Skip to main content

Unigen to Use Omics Tools to Discover Potential Therapeutics in Atlantic Ocean Microbes

NEW YORK (GenomeWeb News) - Unigen Pharmaceuticals and the University of Prince Edward Island will work together to study marine microorganisms from the Atlantic Ocean with the hopes of making discoveries that may lead to new therapeutics and commercial products, Unigen said late last week.
 
The marine collection research will be led by Russell Kerr, Canada Research Chair in Marine Natural Products at UPEI, who has been collecting samples from tropical Atlantic waters for two decades.
 
Unigen will extract the microbes from the samples and fractionate them using a high-throughput purification system, and will test these fractions on "biochemical, genomic, proteomic, in vitro, in vivo, and ex vivo models," the company said.
 
The company said active ingredients will be "separated and identified as leads for the development of pharmaceutical, nutraceutical, cosmoceutical, and functional food products."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.